Changes to the Opioid Dependence Treatment program could make long-acting injectable buprenorphine the best option for many people.

Pharmacists play a vital role supporting patients with chronic pain. Around 1 in 5 Australians experience chronic pain; this rises to 1 in 3...

Pfizer’s Comirnaty COVID-19 vaccine has been provisionally approved by the Therapeutic Goods Administration (TGA) for use as a booster in those aged 16–17 years.

Compounding environments must be designed to minimise contamination risk —  including keeping meal breaks well away from the bench.

Greater access to Home Medicines Reviews (HMRs) offers opportunities to intervene earlier, improve patient outcomes and use healthcare funding more effectively. 

In a move aimed at reducing antibiotic resistance, the Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that four of the most widely prescribed antibiotics...